Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

INTRODUCTION: This study evaluated efficacy and safety/tolerability of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, in Japanese anemic non-dialysis-dependent chronic kidney disease (NDD-CKD) patients. METHODS: In this phase 2, double-blind, 24-week study, NDD-CKD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Akizawa, Tadao, Iwasaki, Manabu, Otsuka, Tetsuro, Reusch, Michael, Misumi, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824366/
https://www.ncbi.nlm.nih.gov/pubmed/30953333
http://dx.doi.org/10.1007/s12325-019-00943-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824366/
https://www.ncbi.nlm.nih.gov/pubmed/30953333
http://dx.doi.org/10.1007/s12325-019-00943-4

Ejemplares similares